Friday, October 18, 2024
HomeTagsChroma Medicine

Chroma Medicine

Chroma Medicine Presents Preclinical In Vivo Data Showing Durable Cholesterol Reduction with a PCSK9-Targeted Epigenetic Editor at the 2023 AHA Scientific Sessions

Chroma Medicine, Inc., a genomic medicine company pioneering single-dose epigenetic editing therapeutics, presented new preclinical data demonstrating that a single administration of its epigenetic...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics